Shineco Life Science Group Hong Kong Co., Limited /
InfiniClone Limited
Shineco Life Science completes purchase of InfiniClone stake
What happened
Shineco Life Science Group Hong Kong Co., Limited closed its acquisition of 51% of InfiniClone Limited on June 18, 2025. InfiniClone became a direct subsidiary of Shineco Life Science.
Consideration included US$19,895,600 in cash and 3,450,000 shares of Shineco, Inc. common stock.
The source
Everything on this page comes from the source below.
Shineco Life Science completes purchase of InfiniClone stake
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly